Sandu Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company will be held on Saturday, the 13th day of November, 2021 at 05.00 pm at the Corporate Office of the Company, Sandu Nagar, D K Sandu Marg, Chembur, Mumbai 400071 to consider the following: To Approve Unaudited Financial Results of the Company for the Quarter 30th September 2021 and Any other matter with the permission of Chairman. In Compliance with the Company’s Code of Conduct for prevention of Insider Trading devised as per the SEBI (Prohibition of Insider Trading) the trading window for dealing in the Securities of the Company has been closed for the Company’s Directors/Officer and designated employees of the Company from the opening of Trading hours on Friday, 01st day of October 2021 till 48 hours after announcement of financial results to public for the Quarter ended 30th September 2021 in compliances with the code of conduct for prevention of Insider Trading.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.45 |
| Dr. Reddys Lab | 1223.60 |
| Cipla | 1230.40 |
| Zydus Lifesciences | 929.00 |
| Lupin | 2331.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: